Aditri Pharma Sciences Private Limited, an envisioned pharmaceutical company is engaged in the collaborative development and manufacturing of niche pharmaceutical products for the generic industry.

Team with over three decades of reliable and professional experience behind it is at the helm of innovation in the manufacturing of Intermediates, APIs, and Formulations.

Aditri Pharma Sciences is Committed to highest standards in health care. We strive to satisfy unmet needs of dosage forms to increase compliance, constantly work on bringing down the cost of PPPY without comprising on quality, efficacy and safety. Aditri Pharma Sciences holds Market Authorizations for API DMF and Finished Dosage (ANDA).

We carefully chose our partners to operate on CDMO model for API and Finished dosages for filing of Unique combinations under current portfolio and under development for SRA markets (USFDA, WHO/Geneva).